Walking-related digital mobility outcomes as clinical trial endpoint measures: protocol for a scoping review

Introduction Advances in wearable sensor technology now enable frequent, objective monitoring of real-world walking. Walking-related digital mobility outcomes (DMOs), such as real-world walking speed, have the potential to be more sensitive to mobility changes than traditional clinical assessments. However, it is not yet clear which DMOs are most suitable for formal validation. In this review, we will explore the evidence on discriminant ability, construct validity, prognostic value and responsiveness of walking-related DMOs in four disease areas: Parkinson’s disease, multiple sclerosis, chronic obstructive pulmonary disease and proximal femoral fracture. Methods and analysis Arksey and O’Malley’s methodological framework for scoping reviews will guide study conduct. We will search seven databases (Medline, CINAHL, Scopus, Web of Science, EMBASE, IEEE Digital Library and Cochrane Library) and grey literature for studies which (1) measure differences in DMOs between healthy and pathological walking, (2) assess relationships between DMOs and traditional clinical measures, (3) assess the prognostic value of DMOs and (4) use DMOs as endpoints in interventional clinical trials. Two reviewers will screen each abstract and full-text manuscript according to predefined eligibility criteria. We will then chart extracted data, map the literature, perform a narrative synthesis and identify gaps. Ethics and dissemination As this review is limited to publicly available materials, it does not require ethical approval. This work is part of Mobilise-D, an Innovative Medicines Initiative Joint Undertaking which aims to deliver, validate and obtain regulatory approval for DMOs. Results will be shared with the scientific community and general public in cooperation with the Mobilise-D communication team. Registration Study materials and updates will be made available through the Center for Open Science’s OSFRegistry (https://osf.io/k7395).

[1]  M. Decramer,et al.  The PROactive innovative conceptual framework on physical activity , 2014, European Respiratory Journal.

[2]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[3]  Jochen Klucken,et al.  A clinical view on the development of technology‐based tools in managing Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[4]  Luca Palmerini,et al.  Assessing Gait in Parkinson’s Disease Using Wearable Motion Sensors: A Systematic Review , 2019, Diseases.

[5]  Max A. Little,et al.  Technology in Parkinson's disease: Challenges and opportunities , 2016, Movement disorders : official journal of the Movement Disorder Society.

[6]  Jennifer C. Goldsack,et al.  Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature Review , 2018, Digital Biomarkers.

[7]  D. Levac,et al.  Scoping studies: advancing the methodology , 2010, Implementation science : IS.

[8]  Lynn Rochester,et al.  Independent domains of gait in older adults and associated motor and nonmotor attributes: validation of a factor analysis approach. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  C. Sforza,et al.  Gait analysis in patients with chronic obstructive pulmonary disease: a systematic review. , 2018, Gait & posture.

[10]  A. Latimer-Cheung,et al.  Understanding leisure‐time physical activity: Voices of people with MS who have moderate‐to‐severe disability and their family caregivers , 2017, Health expectations : an international journal of public participation in health care and health policy.

[11]  Xiaonan Xue,et al.  Gait Dysfunction in Mild Cognitive Impairment Syndromes , 2008, Journal of the American Geriatrics Society.

[12]  Scott A. England,et al.  The influence of gait speed on local dynamic stability of walking. , 2007, Gait & posture.

[13]  R. Motl,et al.  Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis , 2012, Disability and rehabilitation.

[14]  Michael W. Whittle,et al.  Gait Analysis: An Introduction , 1986 .

[15]  W. Zijlstra,et al.  Detection of gait and postures using a miniaturized triaxial accelerometer-based system: accuracy in patients with mild to moderate Parkinson's disease. , 2010, Archives of physical medicine and rehabilitation.

[16]  Sean Khozin,et al.  Developing and adopting safe and effective digital biomarkers to improve patient outcomes , 2019, npj Digital Medicine.

[17]  Michael Schwenk,et al.  The Impact of Mild Cognitive Impairment on Gait and Balance: A Systematic Review and Meta-Analysis of Studies Using Instrumented Assessment , 2016, Gerontology.

[18]  P. Vidal,et al.  Value of gait analysis for measuring disease severity using inertial sensors in patients with multiple sclerosis: protocol for a systematic review and meta-analysis , 2019, Systematic Reviews.

[19]  M. J. Pletcher,et al.  Continuous daily assessment of multiple sclerosis disability using remote step count monitoring , 2017, Journal of Neurology.

[20]  Jeffrey M. Hausdorff,et al.  A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity , 2020, Journal of Neurology.

[21]  R. Puers,et al.  Inertial sensors versus standard systems in gait analysis: a systematic review and meta-analysis. , 2019, European journal of physical and rehabilitation medicine.

[22]  J. Goldhahn.  Need for Digital Biomarkers in Musculoskeletal Trials , 2017, Digital Biomarkers.

[23]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[24]  David R Bassett,et al.  Accelerometer-based physical activity: total volume per day and standardized measures. , 2015, Medicine and science in sports and exercise.

[25]  R. Roubenoff,et al.  How soon will digital endpoints become a cornerstone for future drug development? , 2019, Drug discovery today.

[26]  Tuula Petäkoski-Hult,et al.  Gait analysis and estimation of changes in fall risk factors , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[27]  S. Fritz,et al.  Walking speed: the functional vital sign. , 2015, Journal of aging and physical activity.

[28]  M. Stockler,et al.  The importance of patient-reported outcomes in clinical trials and strategies for future optimization , 2018, Patient related outcome measures.

[29]  Adrian Bauman,et al.  Accelerometer-based measures in physical activity surveillance: current practices and issues , 2014, British Journal of Sports Medicine.

[30]  Anirvan Ghosh,et al.  Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial , 2018, Movement disorders : official journal of the Movement Disorder Society.

[31]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[32]  Xiaonan Xue,et al.  Quantitative gait dysfunction and risk of cognitive decline and dementia , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  M. Sutliff.  Contribution of impaired mobility to patient burden in multiple sclerosis , 2010, Current medical research and opinion.

[34]  B. Celli,et al.  Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. , 2015, Respiratory Medicine.

[35]  Alan Godfrey,et al.  Validation of an Accelerometer to Quantify a Comprehensive Battery of Gait Characteristics in Healthy Older Adults and Parkinson's Disease: Toward Clinical and at Home Use , 2016, IEEE Journal of Biomedical and Health Informatics.

[36]  A. Williams,et al.  International classification of functioning, disability, and health: ICF-CY World Health Organization , 2013 .

[37]  R. Motl,et al.  Physical Activity Correlates With Neurological Impairment and Disability in Multiple Sclerosis , 2008, The Journal of nervous and mental disease.

[38]  E. McAuley,et al.  Longitudinal analysis of physical activity and symptoms as predictors of change in functional limitations and disability in multiple sclerosis. , 2009, Rehabilitation psychology.

[39]  Karen L McCulloch,et al.  Development of a Clinical Measure of Dual‐task Performance in Walking: Reliability and Preliminary Validity of the Walking and Remembering Test , 2009, Journal of geriatric physical therapy.

[40]  M. Morris,et al.  The reliability of three-dimensional kinematic gait measurements: a systematic review. , 2009, Gait & posture.

[41]  Eran Gazit,et al.  Automated detection of missteps during community ambulation in patients with Parkinson’s disease: a new approach for quantifying fall risk in the community setting , 2014, Journal of NeuroEngineering and Rehabilitation.

[42]  Lynn Rochester,et al.  Moving forward on gait measurement: Toward a more refined approach , 2013, Movement disorders : official journal of the Movement Disorder Society.

[43]  Subashan Perera,et al.  Improvements in Speed-Based Gait Classifications Are Meaningful , 2007, Stroke.

[44]  E. Waubant,et al.  EDSS variability before randomization may limit treatment discovery in primary progressive MS , 2013, Multiple sclerosis.

[45]  G. Chard.  International Classification of Functioning, Disability and Health , 2004 .

[46]  J. Fleiss.  Measuring nominal scale agreement among many raters. , 1971 .

[47]  D. Allen,et al.  Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review , 2016, PloS one.

[48]  Kim Delbaere,et al.  Eight-Week Remote Monitoring Using a Freely Worn Device Reveals Unstable Gait Patterns in Older Fallers , 2015, IEEE Transactions on Biomedical Engineering.

[49]  J. Sosnoff,et al.  Novel technology for mobility and balance tracking in patients with multiple sclerosis: a systematic review , 2018, Expert review of neurotherapeutics.

[50]  Ronald C Petersen,et al.  Normative spatiotemporal gait parameters in older adults. , 2011, Gait & posture.

[51]  S. Studenski,et al.  Gait speed and survival in older adults. , 2011, JAMA.

[52]  E. Dorsey,et al.  The First Frontier: Digital Biomarkers for Neurodegenerative Disorders , 2017, Digital Biomarkers.

[53]  B. Galna,et al.  Free-living gait characteristics in ageing and Parkinson’s disease: impact of environment and ambulatory bout length , 2016, Journal of NeuroEngineering and Rehabilitation.

[54]  L. Snyder-Mackler,et al.  Interrater reliability of videotaped observational gait-analysis assessments. , 1991, Physical therapy.

[55]  Jill M van der Meulen,et al.  Free-living and laboratory gait characteristics in patients with multiple sclerosis , 2018, PloS one.

[56]  C. Mazzà,et al.  Free‐living monitoring of Parkinson's disease: Lessons from the field , 2016, Movement disorders : official journal of the Movement Disorder Society.

[57]  Jeffrey M. Hausdorff,et al.  Does the Evaluation of Gait Quality During Daily Life Provide Insight Into Fall Risk? A Novel Approach Using 3-Day Accelerometer Recordings , 2013, Neurorehabilitation and neural repair.

[58]  Martha L Walker,et al.  Reliability of the dynamic gait index in people with vestibular disorders. , 2003, Archives of physical medicine and rehabilitation.

[59]  Ioannis Tarnanas,et al.  Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials , 2018, Alzheimer's & dementia.

[60]  J. Dingwell,et al.  Re-interpreting detrended fluctuation analyses of stride-to-stride variability in human walking. , 2010, Gait & posture.

[61]  S. Fritz,et al.  White paper: "walking speed: the sixth vital sign". , 2009, Journal of geriatric physical therapy.

[62]  James E. Graham,et al.  Assessing walking speed in clinical research: a systematic review. , 2008, Journal of evaluation in clinical practice.

[63]  N. Stergiou,et al.  Nonlinear dynamics indicates aging affects variability during gait. , 2003, Clinical biomechanics.

[64]  D. Stull,et al.  Optimal recall periods for patient-reported outcomes: challenges and potential solutions , 2009, Current medical research and opinion.

[65]  W. Baker,et al.  Walking Speed and Health‐Related Quality of Life in Multiple Sclerosis , 2013, The Patient - Patient-Centered Outcomes Research.

[66]  Michael Schwenk,et al.  Effects of Wearable Sensor-Based Balance and Gait Training on Balance, Gait, and Functional Performance in Healthy and Patient Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2017, Gerontology.

[67]  S. Rubin,et al.  Prognostic Value of Usual Gait Speed in Well‐Functioning Older People—Results from the Health, Aging and Body Composition Study , 2005, Journal of the American Geriatrics Society.